According to Gland Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.88835. At the end of 2023 the company had a P/S ratio of 6.46.
Year | P/S ratio | Change |
---|---|---|
2023 | 6.46 | 1.59% |
2022 | 6.36 | -58.32% |
2021 | 15.3 | 23.56% |
2020 | 12.3 |